DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and K(d)-restricted epitopes

International Immunology

Volumn 9, Issue 8, 1997, Pages 1203-1212

  Kuhröber, Andreas ^a   Wild, Jens ^a   Pudollek, Hans Peter ^a   Chisari, Francis V ^b   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cytotoxic T lymphocyte; Hepatitis B core antigen; MHC class I; Mouse

Indexed keywords

EPITOPE; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; PLASMID DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; EPITOPES, T-LYMPHOCYTE; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDES; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES, DNA; VIRAL CORE PROTEINS;

EID: 0030751906     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.8.1203     Document Type: Article

References (50)

1. Chisari, F. V. and Ferrari, C. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29.
2. Milich, D. R., McLachlan, A., Raney, A. K., Houghten, R. A., Thorton, G. B., Maruyama, T., Hughes, J. L. and Jones, J. E. 1991. Autoantibody production in hepatitis B e antigen transgenic mice elicited with a self T-cell peptide and inhibited with nonself peptides. Proc. Natl Acad. Sci. USA 88:4348.
3. h2 cells is epitope and major histocompatibility complex dependent. J. Virol. 69:2776.
4. b mice. J. Immunol. 156:3687.
5. Vitiello, A., Ishioka, G., Grey, H. M., Rose, R., Farness, P., LaFond, R., Yuan, L., Chisari, F. V., Furze, J. and Bartholomeuz, R. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection., I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341.
6. Tang, D. C., DeVit, M. and Johnston, S. A. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature 356:152.
7. Raz, E., Carson, D. A., Parker, S. E., Parr, T. B., Abai, A. M., Aichinger, G., Gromkowski, S. H., Singh, M., Lew, D. and Yankauckas, M. A. 1994. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl Acad. Sci. USA 91:9519.
8. Pertmer, T. M., Roberts, T. R. and Haynes, J. R. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:6119.
9. Raz, E., Tighe, H., Sato, Y., Corr, M., Dudler, J., Roman, M., Swain, S. L., Spiegelberg, H. L. and Carson, D. A. 1996. Preferential induction of a TH1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl Acad. Sci. USA 93:5141.
10. Davis, H. L., Demeneix, B. A., Quantin, B., Coulombe, J. and Whalen, R. G. 1993. Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle. Hum. Gene Ther. 4:733.
11. Montgomery, D. L., Shiver, J. W., Leander, K. R., Perry, H. C., Friedman, A., Martinez, D., Ulmer, J. B., Donnelly, J. J. and Liu, M. A. 1993. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:777.
12. Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M. and Friedman, A. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745.
13. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C and Robinson, H. L. 1993. DNA Vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA 90:11478.
14. Ulmer, J. B., Deck, R. R., DeWitt, C. M., Friedman, A., Donnelly, J. J. and Liu, M. A. 1994. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541
15. Xiang, Z. Q., Spitalnik, S., Tran, M., Wunner, W. H., Cheng, J. and Ertl, H. C. J. 1994. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199:132.
16. Martins, L. P., Lau, L. L., Asano, M. S. and Ahmed, R. 1995. DNA vaccination against persistent viral infection. J. Virol. 69:2574.
17. Yokoyama, M., Zhang, J. and Whitton, J. L. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684.
18. Sedegah, M., Hedstrom, R., Hobart, P. and Huffman, S. L. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl Acad. Sci. USA 91:9866.
19. Xu, D. and Liew, F. Y. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L major. Immunology 84:173.
20. Schirmbeck, R., Melber, K., Mertens, T. and Reimann, J. 1994. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur. J. Immunol. 24:1088.
21. Schirmbeck, R., Melber, K., Mertens, T. and Reimann, J. 1994. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. J. Virol. 68:1418.
22. + cytotoxic T lymphocyte responses in vivo. J. Immunol. 152:1110.
23. Davis, H. L., Schirmbeck, R., Reimann, J. and Whalen, R. G. 1995. DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to Hepatitis B virus surface antigen. Hum. Gene Ther. 6:1447.
24. Schirmbeck, R., Demi, L., Melber, K., Wolf, H., Wagner, R. and Reimann, J. 1995. Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens. Vaccine 13:857.
25. Schirmbeck, R., Böhm W., Ando, K., Chisari, F. V. and Reimann, J. 1995. Nucleic acid vaccination primes hepatitis B surface antigen-specific cytotoxic T lymphocytes in nonresponder mice J. Virol. 69:5929.
26. Artlelt, P., Morelle, C., Ausmeier, M., Fitzek, M. and Hauser, J. 1988. Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection. Gene 68:213.
27. Schlicht, H.-J. and Schaller, H. 1989. The secretory core protein of human hepatitis B virus is expressed on the cells surface. J. Virol. 63:5399
28. Ljunggren, H.-G. and Kärre, K. 1985. Host resistance directed selectively against H-2 deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162:1745.
29. Karasuyama, H. and Melchers, F. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 and 5, using modified cDNA expression vectors, Eur. J. Immunol. 18:97.
30. Rammensee, H. G., Friede, T. and Stevanoviic, S. 1995. MHC ligands and peptide motifs: first listing, Immunogenetics 41:178.
31. Böhm W., Schirmbeck, R., Elbe, A., Melber, K., Diminsky, D., Kraal, G., Van Rooijen, N., Barenholz, Y. and Reimann, J. 1995. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo J. Immunol. 155:3313.
32. Schirmbeck, R., Melber, K. and Reimann, J. 1995. Hepatitis B virus surface particles are processed in a novel endosomal pathway for MHC class I-restricted epitope presentation. Eur. J. Immunol 25:1063.
33. Schirmbeck, R., Böhm W., Melber, K. and Reimann, J. 1995. Processing of exogenous heat-aggregated (denatured) or particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J. Immunol. 155:4676.
34. Schirmbeck, R., Böhm W. and Reimann, J. 1996. Virus-like particles induce MHC class I-restricted T cell responses. Lessons learned from Hepatitis B virus surface antigen, Intervirology 39:111.
35. Griffiths, J. C., Harris, S. J., Layton, G. T., Berrie, E. L., French, T. J., Burns, N. R., Adams, S. E. and Kingsman, A. J. 1993. Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion. J. Virol. 67:3191.
36. Harris, S. J., Gearing, A. J., Layton, G. T., Adams, S. E. and Kingsman, A. J. 1992. Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles. Immunology 77:315.
37. Layton, G. T., Harris, S. J., Gearing, A. J., Hill Perkins, M., Cole, J. S., Griffiths, J. C., Burns, N. R., Kingsman, A. J. and Adams, S. E. 1993. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J. Immunol. 151:1097.
38. d mice that reject syngeneic tumors. J. Immunol. 157:3550.
39. Yewdell, J. W. and Bennink, J. R. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
40. Engelhard V. H. 1994. Structure of peptides associated with class I and class II MHC molecules. Annu. Rev. Immunol. 12:181.
41. Roelse, J., Gromme, M., Momburg, F., Hammerling, G. and Neefjes, J. 1994. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1591.
42. Guidotti, L. G., Matzke, B., Pasquinelli, C., Schoenberger, J. M., Regler, C. E. and Chisari, F. V. 1996. The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice. J. Virol. 70:7056.
43. + T cells. Nature 364:158.
44. Ferris, R. L., Buck, C., Hammond, S. A., Woods, A. S., Cotter, R. J., Takiguchi, M., Igarashi, Y., Ichikawa, Y. and Siliciano, R. F. 1996. Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins. J. Immunol. 156:834.
45. Rock, K. L. 1996. A new foreign policy: MMHC class I molecules monitor the outside world, Immunol. Today 17:131.
46. Jondal, M., Schirmbeck, R. and Reimann, J. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5:295.
47. Okamoto, H., Tsuda, F., Akahane, Y., Sugai, Y., Yoshiba, M., Moriyama, K., Tanaka, T., Miyakawa, Y. and Mayumi, M. 1994. Hepatitis B virus with mutations in the core promoter for an e-antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 68:8102.
48. Günther, S., Piwon, N. Iwanska, A., Schilling, R., Meisel, H. and Will, H. 1996. Type, prevalence, and significance of core promoter/ enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J. virol. 70:8318.
49. Bertoletti, A., Ferrari, C., Fiaccadori, F., Penna, A., Margolskee, R., Schlicht, H. J., Fowler, P., Guilhot, S. and Chisari, F. V. 1991. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl Acad. Sci. USA 88:10445.
50. Missale, G., Redeker, A., Person, J., Fowler, P., Guilhot, S., Schlicht, H. J., Ferrari, C. and Chisari, F. V. 1993. HLA-A31-and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J. Exp. Med. 177:751.